Table 2 Baseline and achieved hemodynamic parameters and variables during vasopressor support
All patients | No KDIGO stage shift (AKI–) | ≥1 KDIGO stage shift (AKI+) | P value | |
|---|---|---|---|---|
Baseline SAP, mm Hg | 130 (120-138) | 130 (117-137) | 131 (120-142) | 0.592 |
Baseline DAP, mm Hg | 74 (67-84) | 73 (62-82) | 79 (69-85) | 0.163 |
Baseline MAP, mm Hg | 92 (86-101) | 91 (84-99) | 97 (87-103) | 0.154 |
Baseline CVP, mm Hg | 3 (3-8) | 3 (3-8) | 3 (3-8) | 0.018 |
3 mm Hg | 48 (63) | 21 (53) | 27 (75) | |
8 mm Hg | 21 (28) | 12 (30) | 9 (25) | |
15 mm Hg | 7 (9) | 7 (17) | 0 (0) | |
Baseline MPP, mm Hg | 89 (82-97) | 85 (76-93) | 91 (84-99) | 0.035 |
Baseline DPP, mm Hg | 70 (63-81) | 67 (55-76) | 73 (64-81) | 0.047 |
Time on vasopressor, days | 1.3 (0.7-2.7) | 1.2 (0.7-2.3) | 1.4 (0.7-2.8) | 0.303 |
TWA vasopressor rate, μg/kg/min | 0.08 (0.04-0.12) | 0.08 (0.05-0.12) | 0.08 (0.04-0.12) | 0.685 |
Vasopressin | 5 (7) | 2 (5) | 3 (8) | 0.558 |
TWA-SAP achieved, mm Hg | 118 (110-128) | 115 (107-128) | 120 (114-129) | 0.170 |
TWA-DAP achieved, mm Hg | 58 (53-62) | 58 (54-62) | 57 (53-62) | 0.803 |
TWA-MAP achieved, mm Hg | 74 (70-78) | 73 (70-78) | 75 (72-79) | 0.323 |
TWA-CVP achieved, mm Hg | 8.0 (5.7-9.6) | 7.7 (5.6-9.4) | 8.6 (5.8-9.7) | 0.344 |
TWA-MPP achieved, mm Hg | 66 (62-70) | 65 (61-70) | 67 (63-71) | 0.533 |
TWA-DPP achieved, mm Hg | 50 (46-53) | 50 (47-54) | 50 (46-54) | 0.892 |